Scott Thomas Smith
EVP & Chief Financial Officer · 2 filings · Latest: Jun 2, 2026
Ascendis Pharma A/S
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ASND | Scott Thomas Smith | EVP & Chief Financial Officer | Jun 2, 2026 | Purchase | $219.00 | 100 | $21.9K | 4,367 | |
ASND | Scott Thomas Smith | EVP & Chief Financial Officer | May 29, 2026 | Purchase | $223.32 | 250 | $55.8K | 4,267 | |
ASND | SMITH SCOTT THOMAS | — | Mar 5, 2026 | Proposed Sale | $240.00 | 10,000 | $2.4M | — | Mar 6 1:44 PM 144/A |
ASND | SMITH SCOTT THOMAS | — | Mar 5, 2026 | Proposed Sale | $240.00 | 10,000 | $2.4M | — | |
ASND | SMITH SCOTT THOMAS | — | Mar 2, 2026 | Proposed Sale | $242.09 | 18,349 | $4.4M | — | |
ASND | SMITH SCOTT THOMAS | — | Aug 12, 2025 | Proposed Sale | $192.57 | 10,000 | $1.9M | — | |
ASND | SMITH SCOTT THOMAS | — | Mar 4, 2025 | Proposed Sale | $152.12 | 13,344 | $2.0M | — | |
ASND | SMITH SCOTT THOMAS | — | Feb 20, 2025 | Proposed Sale | $154.27 | 10,000 | $1.5M | — | |
ASND | SMITH SCOTT THOMAS | — | Dec 10, 2024 | Proposed Sale | $129.13 | 2,119 | $273.6K | — |